Skip to content

Skin Efficacy Testing of Astrion Products

Skin Efficacy Testing of Astrion Products

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06657352
Enrollment
150
Registered
2024-10-24
Start date
2022-11-28
Completion date
2023-09-30
Last updated
2024-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Pigment, Skin Red

Brief summary

This project aims to conduct safety and efficacy tests on the skin for the ingestion of Astrion Vitality Capsules, containing A. membranaceus and C. Asiatica roots, and the topical application of Astrion Vitality Cream. The goal is to develop health and skincare products that regulate physiological functions, promote overall wellness, and enhance skin beauty.

Interventions

DIETARY_SUPPLEMENTACS Topical Treatment Group

The topical group applied the ACS cream to the face twice daily (morning and night) for 4 weeks.

DIETARY_SUPPLEMENTTopical Placebo Group

The topical group applied the cream (without ACS) to the face twice daily (morning and night) for 4 weeks.

DIETARY_SUPPLEMENTOral Treatment + Topical Treatment Group

The combination group used both the topical and oral ACS products for 12 weeks.

DIETARY_SUPPLEMENTACS Oral Treatment Group

The oral group ingested one ACS capsule twice daily after breakfast and dinner for 12 weeks.

DIETARY_SUPPLEMENTOral Placebo Group

The oral group ingested one capsule (without ACS) twice daily after breakfast and dinner for 12 weeks.

DIETARY_SUPPLEMENTOral Treatment + Topical Placebo Group

The combination group used both the topical and oral products without ACS for 12 weeks.

Sponsors

Chia Nan University of Pharmacy & Science
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subjects aged ≥18 years.

Exclusion criteria

* Non-voluntary participants. * Subjects diagnosed with skin diseases, cirrhosis, or chronic renal failure by a -physician. * Individuals with known allergies to cosmetics, drugs, or food. * Pregnant or breastfeeding women. * Individuals taking medication for chronic diseases. * Subjects who, within 12 weeks prior to the test, have undergone laser facial treatments, chemical peels, or experienced prolonged sun exposure (more than 3 hours of direct sunlight in a week). * Students taught by the investigator. * Individuals unwilling to allow the publication of photos of the experimental results.

Design outcomes

Primary

MeasureTime frameDescription
skin melaninThe topical group applied ACS cream to the face twice daily for 4 weeks. The oral group took one ACS capsule twice daily after meals for 12 weeks. The combination group followed both regimens for 12 weeks. A placebo group, identical in appearance but witSkin elastometer (Soft Plus) was utilized to measure skin melanin. Units: arbitrary units
Skin brightnessThe topical group applied ACS cream to the face twice daily for 4 weeks. The oral group took one ACS capsule twice daily after meals for 12 weeks. The combination group followed both regimens for 12 weeks. A placebo group, identical in appearance but witSkin color difference analyzer (Chroma Meter MM500) was utilized to measure skin brightness
skin moistureThe topical group applied ACS cream to the face twice daily for 4 weeks. The oral group took one ACS capsule twice daily after meals for 12 weeks. The combination group followed both regimens for 12 weeks. A placebo group, identical in appearance but witSkin moisture meter (Corneometer CM825) was utilized to measure skin moisture. Units: arbitrary units
skin elasticityThe topical group applied ACS cream to the face twice daily for 4 weeks. The oral group took one ACS capsule twice daily after meals for 12 weeks. The combination group followed both regimens for 12 weeks. A placebo group, identical in appearance but witSkin elastometer (Soft Plus) was utilized to measure skin elasticity. Units: arbitrary units
collagen density contentThe topical group applied ACS cream to the face twice daily for 4 weeks. The oral group took one ACS capsule twice daily after meals for 12 weeks. The combination group followed both regimens for 12 weeks. A placebo group, identical in appearance but witSubcutaneous collagen scanner (DermaLab® Series SkinLab Combo) was utilized to measure skin collagen. Units: arbitrary units
skin surface topographyThe topical group applied ACS cream to the face twice daily for 4 weeks. The oral group took one ACS capsule twice daily after meals for 12 weeks. The combination group followed both regimens for 12 weeks. A placebo group, identical in appearance but witVISIA Micro-Analysis Skin Image Analyzer was utilized to measure skin texture. Units: arbitrary units

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026